NCT02875002 2017-12-22Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell LymphomasYale UniversityPhase 1 Withdrawn
NCT02861040 2016-12-15Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaNorthwestern UniversityPhase 1 Withdrawn